Skandinaviska Enskilda Banken Ab (Publ) Integra Lifesciences Holdings Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.86 - $66.52 $254,111 - $313,841	-4,718 Reduced 30.71%	10,645 $575,000
Q1 2022 May 11, 2022	SELL	$62.86 - $69.24 $479,370 - $528,024	-7,626 Reduced 33.17%	15,363 $987,000
Q3 2021 Nov 10, 2021	SELL	$64.97 - $76.19 $88,554 - $103,846	-1,363 Reduced 5.6%	22,989 $1.57 Million
Q2 2021 Aug 10, 2021	BUY	$66.79 - $76.63 $46,419 - $53,257	695 Added 2.94%	24,352 $1.66 Million
Q1 2021 May 14, 2021	BUY	$62.63 - $71.15 $21,983 - $24,973	351 Added 1.51%	23,657 $1.63 Million
Q4 2020 Feb 11, 2021	BUY	$43.31 - $66.55 $276,274 - $424,522	6,379 Added 37.69%	23,306 $1.51 Million
Q3 2020 Nov 12, 2020	BUY	$43.33 - $51.72 $716,894 - $855,707	16,545 Added 4331.15%	16,927 $799,000
Q2 2020 Aug 13, 2020	BUY	$41.42 - $55.57 $15,822 - $21,227	382 New	382 $18,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.